Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 20004966

Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2009 Dec 19
First author
Albain KS

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2009 Dec 19;374(9707):2029-2030. doi: 10.1016/S0140-6736(09)62097-3.
    note
    Source null
    related pmid
    20004965
    relationship
    Comment in
  2. citation
    Womens Health (Lond). 2010 May;6(3):357-60. doi: 10.2217/whe.10.22.
    note
    Source null
    related pmid
    20426600
    relationship
    Comment in
  3. citation
    Lancet. 2010 May 29;375(9729):1870-1; author reply 1871-2. doi: 10.1016/S0140-6736(10)60867-7.
    note
    Source null
    related pmid
    20511010
    relationship
    Comment in
  4. citation
    Lancet. 2010 May 29;375(9729):1871; author reply 1871-2. doi: 10.1016/S0140-6736(10)60868-9.
    note
    Source null
    related pmid
    20511012
    relationship
    Comment in

Authors and identifiers

  1. name
    Albain KS
    type
    Author
  2. name
    Barlow WE
    type
    Author
  3. name
    Ravdin PM
    type
    Author
  4. name
    Farrar WB
    type
    Author
  5. name
    Burton GV
    type
    Author
  6. name
    Ketchel SJ
    type
    Author
  7. name
    Cobau CD
    type
    Author
  8. name
    Levine EG
    type
    Author
  9. name
    Ingle JN
    type
    Author
  10. name
    Pritchard KI
    type
    Author
  11. name
    Lichter AS
    type
    Author
  12. name
    Schneider DJ
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Albain KS
    type
    Author
  2. name
    Barlow WE
    type
    Author
  3. name
    Ravdin PM
    type
    Author
  4. name
    Farrar WB
    type
    Author
  5. name
    Burton GV
    type
    Author
  6. name
    Ketchel SJ
    type
    Author
  7. name
    Cobau CD
    type
    Author
  8. name
    Levine EG
    type
    Author
  9. name
    Ingle JN
    type
    Author
  10. name
    Pritchard KI
    type
    Author
  11. name
    Lichter AS
    type
    Author
  12. name
    Schneider DJ
    type
    Author
bibliography ids
  1. nci-bib-616f8cd555732b70408c8c2d
book metadata
content sha256
0823164038ff3ac05b095a098b469466ca5515b2f59114adfb115b5601d31847
document type
citation
dois
  1. 10.1016/S0140-6736(09)61523-3
electronic publication date
display
2009 Dec 10
precision
day
year
2009
evidence scope
bibliographic_metadata_only
id
pubmed:20004966
immutable id
pubmed:20004966@0823164038ff3ac05b095a098b469466ca5515b2f59114adfb115b5601d31847
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
9707
name
Lancet (London, England)
nlm unique id
2985213R
pages
2055-2063
volume
374
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2009 Dec 19;374(9707):2029-2030. doi: 10.1016/S0140-6736(09)62097-3.
    note
    Source null
    related pmid
    20004965
    relationship
    Comment in
  2. citation
    Womens Health (Lond). 2010 May;6(3):357-60. doi: 10.2217/whe.10.22.
    note
    Source null
    related pmid
    20426600
    relationship
    Comment in
  3. citation
    Lancet. 2010 May 29;375(9729):1870-1; author reply 1871-2. doi: 10.1016/S0140-6736(10)60867-7.
    note
    Source null
    related pmid
    20511010
    relationship
    Comment in
  4. citation
    Lancet. 2010 May 29;375(9729):1871; author reply 1871-2. doi: 10.1016/S0140-6736(10)60868-9.
    note
    Source null
    related pmid
    20511012
    relationship
    Comment in
outcomes validated
false
pmid
20004966
provenance
batch id
708c7929ee1eff455330
provider
NCBI PubMed ESummary
record sha256
0b23793738206ce1f346c9146e0de2e6038674afe02183e6854a576146e3786f
response sha256
d245af3dbc636ffc79325b3798c7bfda16faf0a3d796681b12b8d89bd68eb450
retrieved at
2026-09-09T23:46:31.496840+00:00
publication date
display
2009 Dec 19
precision
day
year
2009
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Randomized Controlled Trial
  4. Research Support, N.I.H., Extramural
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/20004966/
title
Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial.

Preserved source evidence · Not medical advice